This Amedeo Smart survey is supported by AngelsInitiative.com.
AmedeoCytomegalovirus Infection |
|
Free Subscription
Transplantation |
- September 2025
- GARDINER BJ, Lee SJ, Snell GI, Westall GP, et al
Response to Letter: Global Immune Biomarkers and Donor Serostatus Can Predict Cytomegalovirus Infection Within Seropositive Lung Transplant Recipients.
Transplantation. 2025 Sep 17. doi: 10.1097/TP.0000000000005531.
>> Share
August 2025 - DENG ZQ, Yan HJ, Tian D
Predicting Cytomegalovirus Infection in Seropositive Lung Transplant Recipients: How to Improve the Predictive Performance?
Transplantation. 2025 Aug 29. doi: 10.1097/TP.0000000000005517.
>> Share
May 2025 - GARDINER BJ, Lee SJ, Robertson AN, Snell GI, et al
Global Immune Biomarkers and Donor Serostatus Can Predict Cytomegalovirus Infection Within Seropositive Lung Transplant Recipients.
Transplantation. 2025 May 20. doi: 10.1097/TP.0000000000005422.
>> Share
April 2025 - KOTTON CN, Kumar D, Manuel O, Chou S, et al
The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation.
Transplantation. 2025 Apr 9. doi: 10.1097/TP.0000000000005374.
>> Share
- WONG G, Li J
Standardizing Care and Management of Cytomegalovirus Infections in Solid Organ Transplant Recipients: Highlights From the Fourth Consensus Guidelines.
Transplantation. 2025 Apr 9. doi: 10.1097/TP.0000000000005380.
>> Share
March 2025 - GARDINER BJ, Westall GP, Sester M, Torre-Cisneros J, et al
Immune Monitoring Assays: Predicting Cytomegalovirus and Other Infections in Solid Organ Transplant Recipients.
Transplantation. 2025;109:395-398.
>> Share
December 2024 - VERA-ARIAS CA, Garcia-Rios E, Perez-Romero P
NPC-21: A Potential Game Changer in the Fight Against Cytomegalovirus Disease in Transplant Recipients.
Transplantation. 2024 Dec 9. doi: 10.1097/TP.0000000000005284.
>> Share
November 2024 - ICHIMARU N, Natori Y, Alloway RR, Wojciechowski D, et al
Phase 2, Randomized, Double-blind, Placebo-controlled Study of Fiztasovimab (NPC-21) for Kidney Transplant Recipients at High Risk of Cytomegalovirus Infection (LionHeart21).
Transplantation. 2024 Nov 6. doi: 10.1097/TP.0000000000005260.
>> Share
October 2024 - BERTO CG, Kotton CN
Promises and Pitfalls of CMV Cell-mediated Immunity in Solid Organ Transplant.
Transplantation. 2024 Oct 15. doi: 10.1097/TP.0000000000005207.
>> Share
September 2024 - HORSTEN F, Chou S, Gillemot S, Debaveye Y, et al
Dynamics and Evolution of Donor-derived Cytomegalovirus Infection in 3 Solid Organ Transplant Recipients With the Same Multiorgan Donor.
Transplantation. 2024 Sep 30. doi: 10.1097/TP.0000000000005209.
>> Share
August 2024 - SOLERA JT, Ferreira VH, Cervera C, Hosseini-Moghaddam SM, et al
Cell-mediated Immunity to Guide Primary Prophylaxis for CMV Infection in Organ Transplant Recipients: A Multicenter Single-arm Prospective Study.
Transplantation. 2024 Aug 20. doi: 10.1097/TP.0000000000005173.
>> Share
April 2024 - PENNINGTON KM, Martin MJ, Murad MH, Sanborn D, et al
Risk Factors for Early Fungal Disease in Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis.
Transplantation. 2024;108:970-984.
>> Share
January 2024 - ROBERTS MB, Kotton CN
Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial.
Transplantation. 2024 Jan 26. doi: 10.1097/TP.0000000000004908.
>> Share
- ROBERTS MB, Kotton CN
Letermovir Prophylaxis After Kidney Transplantation: Another Tool but Not a Revolution Yet.
Transplantation. 2024;108:7-9.
>> Share
December 2023 - QIU Y, Zhang Y, Teng M, Cheng S, et al
Efficacy, Safety, and Cost-effectiveness Analysis of Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Transplantation. 2023 Dec 5. doi: 10.1097/TP.0000000000004856.
>> Share
November 2023 - REUSING JO JR, Agena F, Kotton CN, Campana G, et al
QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients.
Transplantation. 2023 Nov 22. doi: 10.1097/TP.0000000000004870.
>> Share
October 2023 - STEWART AG, Kotton CN
What's New: Updates on Cytomegalovirus in Solid Organ Transplantation.
Transplantation. 2023 Oct 30. doi: 10.1097/TP.0000000000004855.
>> Share
August 2023 - TONIATO DE REZENDE FRESCHI J, Cristelli MP, Viana LA, Ficher KN, et al
A Head-to-head Comparison of De Novo Sirolimus or Everolimus Plus Reduced-dose Tacrolimus in Kidney Transplant Recipients: A Prospective and Randomized Trial.
Transplantation. 2023 Aug 1. doi: 10.1097/TP.0000000000004749.
>> Share
May 2023 - BLOM KB, Birkeland GK, Midtvedt K, Jenssen TG, et al
Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management.
Transplantation. 2023 May 26. doi: 10.1097/TP.0000000000004615.
>> Share
- KOTTON CN
The Best Method for CMV Prevention in High-risk Kidney Transplant Recipients? Either, per National Norwegian Transplant Database: Commentary on Blom et al, Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes
Transplantation. 2023 May 22. doi: 10.1097/TP.0000000000004616.
>> Share
April 2023 - VIANA LA, Cristelli MP, Basso G, Santos DW, et al
Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial.
Transplantation. 2023 Apr 13. doi: 10.1097/TP.0000000000004559.
>> Share
- PIERROTTI LC, Clemente WT
New Perspectives in Cytomegalovirus After Transplant: The Role of Immunosuppressant Management.
Transplantation. 2023 Apr 13. doi: 10.1097/TP.0000000000004560.
>> Share
March 2023 - HIGDON LE, Tan JC, Maltzman JS
Infection, Rejection, and the Connection.
Transplantation. 2023;107:584-595.
>> Share
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016
